89Zr- girentuximab (89Zirconium-girentuximab)
Showing 1 - 25 of 117
Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)
Available
- Clear Cell Renal Cell Carcinoma
- 89Zr-DFO-girentuximab
-
Los Angeles, CaliforniaUCLA
Oct 12, 2023
Triple Negative Breast Cancer Trial in Saint-Herblain (89Zr-TLX250 PET/CT)
Recruiting
- Triple Negative Breast Cancer
- 89Zr-TLX250 PET/CT
-
Saint-Herblain, FranceICO René Gauducheau
Oct 18, 2021
Urothelial Carcinoma Trial in Murdoch (89Zr-Girentuximab)
Recruiting
- Urothelial Carcinoma
- Bladder Cancer
-
Murdoch, Western Australia, AustraliaFiona Stanley Hospital
Aug 22, 2021
Urothelial Carcinoma Trial in Murdoch (89Zr-Girentuximab)
Recruiting
- Urothelial Carcinoma
-
Murdoch, Western Australia, AustraliaFiona Stanley Hospital
Sep 8, 2021
Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)
Not yet recruiting
- Cervical Cancer
- +13 more
- (no location specified)
Sep 28, 2022
Bladder Cancer Trial in Saint Herblain (89Zr-TLX250 PET/CT)
Recruiting
- Bladder Cancer
- 89Zr-TLX250 PET/CT
-
Saint Herblain, FranceInstitut de cancerologie de l'Ouest
Nov 24, 2021
Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial
Not yet recruiting
- Clear Cell Renal Cell Carcinoma
- +2 more
- (no location specified)
May 14, 2023
Clear Cell Renal Cell Carcinoma Trial in Worldwide (89Zr-girentuximab)
Recruiting
- Clear Cell Renal Cell Carcinoma
- 89Zr-girentuximab
-
Duarte, California
- +29 more
Aug 4, 2021
Solid Tumor, Adult, Advanced Solid Tumor, Advanced Renal Cell Carcinoma Trial in Australia (89Zr-TLX250, 177Lu-TLX250 and
Recruiting
- Solid Tumor, Adult
- +2 more
- 89Zr-TLX250
- 177Lu-TLX250 and Peposertib
-
North Ryde, New South Wales, Australia
- +4 more
May 22, 2023
Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)
Not yet recruiting
- Multiple Myeloma
- Plasma Cell Myeloma
- Zirconium Zr 89-DFO-YS5
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 26, 2023
Melanoma, Renal Cell Carcinoma Trial in Hull (Zirconium 89Zr crefmirlimab berdoxam)
Recruiting
- Melanoma
- Renal Cell Carcinoma
- Zirconium 89Zr crefmirlimab berdoxam
-
Hull, United KingdomCastle Hill Hospital
Feb 15, 2023
89Zr-Bevacizumab PET/CT Imaging in NF2 Patients
Recruiting
- Neurofibromatosis 2
- Bevacizumab Zirconium Zr-89
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Center
Jan 5, 2023
Carcinoma, Renal Cell, Clear Cell Renal Cell Carcinoma Trial in Yokohama City (89Zr-girentuximab)
Completed
- Carcinoma, Renal Cell
- Clear Cell Renal Cell Carcinoma
- 89Zr-girentuximab
-
Yokohama City, Kanagawa, JapanYokohama City University Hospital
Aug 18, 2021
Metastatic Malignant Solid Tumor Trial in Duarte (procedure, radiation, drug)
Recruiting
- Metastatic Malignant Solid Neoplasm
- Lymphoma
- Positron Emission Tomography
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
NSCLC Trial in Heidelberg (89Zirconium-M7824, M7824)
Terminated
- Non-Small Cell Lung Cancer
- 89Zirconium-M7824
- M7824
-
Heidelberg, Victoria, AustraliaAustin Health
Jan 13, 2023
Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +2 more
- Panitumumab
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Feb 16, 2023
Rheumatoid Arthritis Trial in San Francisco (89Zr-DFO-CZP)
Suspended
- Rheumatoid Arthritis
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 7, 2022
Clear Cell Renal Cell Carcinoma, Kidney Cancer, Advanced Renal Cell Carcinoma Trial in United States
Recruiting
- Clear Cell Renal Cell Carcinoma
- +2 more
- 177Lu-labeled-girentuximab
- +3 more
-
Basking Ridge, New Jersey
- +6 more
Feb 16, 2022
Advanced Solid Tumor Trial in Amsterdam, Groningen (89Zr-S095012 tracer and S095012 will be administered via an IV infusion)
Recruiting
- Advanced Solid Tumor
- 89Zr-S095012 tracer and S095012 will be administered via an IV infusion
-
Amsterdam, Netherlands
- +1 more
Dec 9, 2022
Breast Cancer Trial in Birmingham ([89Zr]-Df-Trastuzumab, PET/MRI Imaging)
Recruiting
- Breast Cancer
- [89Zr]-Df-Trastuzumab
- PET/MRI Imaging
-
Birmingham, AlabamaThe Kirklin Clinic
Feb 1, 2022
Urinary Bladder Tumors, Colorectal Cancer, NSCLC Trial in Worldwide (AZD8853, Zirconium-89 crefmirlimab berdoxam)
Recruiting
- Urinary Bladder Neoplasms
- +2 more
- AZD8853
- Zirconium-89 crefmirlimab berdoxam
-
New Haven, Connecticut
- +14 more
Aug 8, 2022
Solid Tumor Trial in Amsterdam (Cripec Docetaxel)
Completed
- Solid Tumor
- Cripec Docetaxel
-
Amsterdam, Noord- Holland, NetherlandsVU University Medical Center
Oct 6, 2020
IMaging PAtients for Cancer Drug selecTion - Renal Cell
Completed
- Clear-cell Metastatic Renal Cell Carcinoma
- Kidney Neoplasms
- Molecular imaging
-
Amsterdam, Netherlands
- +2 more
Dec 6, 2021
Clear Cell Renal Carcinoma Trial in Nijmegen (89Zr-Girentuximab)
Completed
- Clear Cell Renal Carcinoma
- 89Zr-Girentuximab
-
Nijmegen, NetherlandsRadboud University
Mar 29, 2019